{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:10:15Z","timestamp":1781507415769,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":3256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.micinf.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T21:50:24Z","timestamp":1417297824000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Towards broadly protective polyvalent vaccines against hand, foot and mouth disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Qingwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2014.11.004_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3949\/ccjm.81a.13132","article-title":"Hand, foot, and mouth disease: identifying and managing an acute viral syndrome","volume":"81","author":"Repass","year":"2014","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.micinf.2014.11.004_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.72","article-title":"Children of rural-to-urban migrant workers in China are at a higher risk of contracting severe hand, foot and mouth disease and EV71 infection: a hospital-based study","volume":"2","author":"Zeng","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.micinf.2014.11.004_bib3","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.jinf.2013.09.020","article-title":"The enteroviruses: problems in need of treatments","volume":"68","author":"Abzug","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.micinf.2010.03.006","article-title":"Neural pathogenesis of enterovirus 71 infection","volume":"12","author":"Weng","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib5","first-page":"615","article-title":"Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus","volume":"79","author":"Robinson","year":"1958","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.micinf.2014.11.004_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12250-011-3195-8","article-title":"Hand foot and mouth disease due to enterovirus 71 in Malaysia","volume":"26","author":"Chua","year":"2011","journal-title":"Virol Sin"},{"key":"10.1016\/j.micinf.2014.11.004_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coviro.2014.03.007","article-title":"Update on enterovirus 71 infection","volume":"5","author":"Huang","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib8","doi-asserted-by":"crossref","first-page":"e90624","DOI":"10.1371\/journal.pone.0090624","article-title":"Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity","volume":"9","author":"Bessaud","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2014.11.004_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.micinf.2014.11.004_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2010.02.002","article-title":"Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland","volume":"48","author":"Blomqvist","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2014.49","article-title":"Receptors for enterovirus 71","volume":"3","author":"Yamayoshi","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1743-422X-8-508","article-title":"Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.11.004_bib14","first-page":"334","article-title":"To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008","volume":"23","author":"Zhang","year":"2009","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.micinf.2014.11.004_bib15","first-page":"339","article-title":"Analysis on the epidemiological and genetic characteristics of enterovirus type 71 and Coxsackie A16 virus infection in Jiangsu, China","volume":"30","author":"Pan","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.micinf.2014.11.004_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00705-010-0722-0","article-title":"Emergence of enterovirus 71 \u201cdouble-recombinant\u201d strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71","volume":"155","author":"Yip","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.11.004_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-012-0237-z","article-title":"Progress on the research and development of human enterovirus 71 (EV71) vaccines","volume":"7","author":"Liang","year":"2013","journal-title":"Front Med"},{"key":"10.1016\/j.micinf.2014.11.004_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2014.29","article-title":"EV71 vaccines: a milestone in the history of global vaccine development","volume":"3","author":"Lu","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jfma.2012.12.001","article-title":"Is a monovalent vaccine against enterovirus 71 sufficient? A review of enterovirus 71 vaccine development based on enterovirus surveillance in Taiwan","volume":"112","author":"Chu","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.micinf.2014.11.004_bib21","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to licensure of enterovirus 71 vaccines","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.micinf.2014.11.004_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2014.11.004_bib24","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the far east?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib25","doi-asserted-by":"crossref","first-page":"e34834","DOI":"10.1371\/journal.pone.0034834","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"Chou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib26","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.vaccine.2013.03.015","article-title":"A phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine","volume":"31","author":"Cheng","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib27","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/14760584.2014.897617","article-title":"Development of enterovirus 71 vaccines: from the lab bench to phase III clinical trials","volume":"13","author":"Li","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2014.11.004_bib29","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2014.11.004_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2014.11.004_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2014.11.004_bib32","doi-asserted-by":"crossref","first-page":"e100545","DOI":"10.1371\/journal.pone.0100545","article-title":"Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.tibtech.2013.09.002","article-title":"Virus-like particle-based human vaccines: quality assessment based on structural and functional properties","volume":"31","author":"Zhao","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.micinf.2014.11.004_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1024071514438","article-title":"Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells","volume":"25","author":"Hu","year":"2003","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.micinf.2014.11.004_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3748\/wjg.v12.i6.921","article-title":"Expression, purification and characterization of enterovirus-71 virus-like particles","volume":"12","author":"Chung","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.micinf.2014.11.004_bib36","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.vaccine.2011.12.081","article-title":"Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles","volume":"30","author":"Lin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib38","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib39","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1016\/j.vaccine.2010.08.052","article-title":"Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield","volume":"28","author":"Chung","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib40","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib41","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1099\/vir.0.80784-0","article-title":"Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys","volume":"86","author":"Arita","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib42","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1128\/JVI.02856-06","article-title":"An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys","volume":"81","author":"Arita","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2014.11.004_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1743-422X-7-106","article-title":"Monoclonal antibody induced with inactivated EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection","volume":"7","author":"Chang","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.11.004_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib46","doi-asserted-by":"crossref","first-page":"831282","DOI":"10.1155\/2012\/831282","article-title":"Immunological evaluation and comparison of different EV71 vaccine candidates","volume":"2012","author":"Chou","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.micinf.2014.11.004_bib47","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.micinf.2006.01.021","article-title":"Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71","volume":"8","author":"Chiu","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00705-012-1589-z","article-title":"Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71","volume":"158","author":"Yu","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.micinf.2014.11.004_bib50","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib51","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib52","doi-asserted-by":"crossref","first-page":"e41381","DOI":"10.1371\/journal.pone.0041381","article-title":"Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon","volume":"7","author":"Tian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-422X-11-79","article-title":"Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice","volume":"11","author":"Li","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.11.004_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3181\/00379727-90-22088","article-title":"Recently classified types of Coxsackie virus, group A; behavior in tissue culture","volume":"90","author":"Sickles","year":"1955","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.micinf.2014.11.004_bib56","doi-asserted-by":"crossref","first-page":"e56318","DOI":"10.1371\/journal.pone.0056318","article-title":"Phylogenetic analysis of enterovirus 71 circulating in Beijing, China from 2007 to 2009","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2014.11.004_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2014.11.004_bib58","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib59","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4161\/hv.27295","article-title":"The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems","volume":"10","author":"Qi An","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.micinf.2014.11.004_bib60","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1099\/vir.0.063560-0","article-title":"Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates","volume":"95","author":"Li","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib61","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/hv.28083","article-title":"Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line","volume":"10","author":"Yang","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.micinf.2014.11.004_bib62","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib63","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.micinf.2014.11.004_bib64","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1007\/s00253-013-5257-3","article-title":"Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice","volume":"97","author":"Zhao","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.micinf.2014.11.004_bib65","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2014.04.001","article-title":"Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: coxsackievirus A6 has emerged as the predominant causative agent","volume":"69","author":"Li","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.micinf.2014.11.004_bib67","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3201\/eid1904.121666","article-title":"Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012","volume":"19","author":"Puenpa","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2014.11.004_bib68","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib69","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2014.11.004_bib70","doi-asserted-by":"crossref","first-page":"670506","DOI":"10.1155\/2014\/670506","article-title":"Immunogenicity studies of bivalent inactivated virions of EV71\/CVA16 formulated with submicron emulsion systems","volume":"2014","author":"Lin","year":"2014","journal-title":"Biomed Res Int"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457914003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457914003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:35:00Z","timestamp":1761143700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457914003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1286457914003001"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2014.11.004","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards broadly protective polyvalent vaccines against hand, foot and mouth disease","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institut Pasteur. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}